Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection

Jose A. Sánchez, Antonio Rodríguez-Sinovas, Ignasi Barba, Elisabet Miró-Casas, Celia Fernández-Sanz, Marisol Ruiz-Meana, Juan J. Alburquerque-Béjar, David García-Dorado

Research output: Contribution to journalArticleResearchpeer-review

29 Citations (Scopus)

Abstract

Connexin 43 (Cx43) deficiency increases myocardial tolerance to ischemia-reperfusion injury and abolishes preconditioning protection. It is not known whether modifications in baseline signaling through protective RISK or SAFE pathways or in response to preconditioning may contribute to these effects. To answer this question we used Cx43Cre-ER(T)/fl mice, in which Cx43 expression is abolished after 4-hydroxytamoxifen (4-OHT) administration. Isolated hearts from Cx43Cre-ER(T)/fl mice, or from Cx43 fl/fl controls, treated with vehicle or 4-OHT, were submitted to global ischemia (40 min) and reperfusion. Cx43 deficiency was associated with reduced infarct size after ischemia-reperfusion (11.17 ± 3.25 % vs. 65.04 ± 3.79, 59.31 ± 5.36 and 65.40 ± 4.91, in Cx43 fl/fl animals treated with vehicle, Cx43fl/fl mice treated with 4-OHT, and Cx43Cre-ER(T)/fl mice treated with vehicle, respectively, n = 8-9, p < 0.001). However, the ratio phosphorylated/total protein expression for Akt, ERK-1/2, GSK3β and STAT3 was not increased in normoxic samples from animals lacking Cx43. Instead, a reduction in the phosphorylation state of GSK3β was observed in Cx43-deficient mice (ratio: 0.15 ± 0.02 vs. 0.56 ± 0.11, 0.77 ± 0.15, and 0.46 ± 0.14, respectively, n = 5-6, p < 0.01). Furthermore, ischemic preconditioning (IPC, 4 cycles of 3.5 min of ischemia and 5 min of reperfusion) increased phosphorylation of ERK-1/2, GSK3β, and STAT3 in all hearts without differences between groups (n = 5-6, p < 0.05), although Cx43 deficient mice were not protected by either IPC or pharmacological preconditioning with diazoxide. Our data demonstrate that modification of RISK and SAFE signaling does not contribute to the role of Cx43 in the increased tolerance to myocardial ischemia-reperfusion injury and in preconditioning protection. © 2013 Springer-Verlag Berlin Heidelberg.
Original languageEnglish
Article number351
JournalBasic Research in Cardiology
Volume108
Issue number3
DOIs
Publication statusPublished - 18 Apr 2013

Keywords

  • Connexin 43
  • Infarction
  • Ischemia-reperfusion
  • Preconditioning

Fingerprint Dive into the research topics of 'Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection'. Together they form a unique fingerprint.

Cite this